We first found that the diagnosis of MetS decreased serum PSA levels by 11.3% compared to the absence of MetS after adjustment with a larger PV in MetS patients, at the same time, there is a linear relationship between the decrease of PSA and the number of components of metabolic syndrome [9]. The gene discussed is KLK3; the disease is metabolic syndrome.